Hikma Pharmaceuticals falls Friday, underperforms market
Shares of Hikma Pharmaceuticals PLC HIK inched down 0.35% to £19.82 Friday, on what proved to be an all-around favorable ...
FDA approves first generic liraglutide once-daily injection
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...
조선일보2d
FDA approves generic Victoza, expects improved supply of obesity drug Saxenda
The generic of Victoza, developed by the U.K.'s Hikma Pharmaceuticals, is set to be launched across the United States by the ...
Monthly Prescribing Reference2d
FDA Approves First Generic Version of Victoza for Type 2 Diabetes
The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.
ConsumerAffairs2d
FDA approves generic GLP-1 drug to treat type 2 diabetes
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
Future Market Insights3d
Global Dyspnea Treatment Market is expected to hit USD 12.3 Billion & rise at a CAGR of 6.9% by forecast period 2033 | Future Market Insights, Inc.
The global dyspnea treatment market, valued at USD 6.31 billion in 2023, is poised for remarkable growth, with projections ...
Managed Healthcare Executive4d
FDA Approves First Once-Daily Generic of Victoza for Type 2 Diabetes
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
3bmedianews4d
F.D.A. APPROVES FIRST GENERIC ONCE-DAILY GLP-1 INJECTION
Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 ...
Hikma Pharmaceuticals rises Tuesday, still underperforms market
Shares of Hikma Pharmaceuticals PLC HIK inched up 0.05% to £19.89 Tuesday, on what proved to be an all-around great trading ...
AstraZeneca withdraws application for lung cancer drug in EU
AstraZeneca has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its ...
The Pharma Letter4d
FDA approves first generic of Victoza
The US Food and Drug Administration (FDA) revealed on Monday that it has approved the first generic referencing Victoza ...
FDA Approves First Generic Of Once-Daily GLP-1 Injection To Lower Blood Sugar In Patients With Type 2 Diabetes
Liraglutide improves blood sugar levels by creating similar effects in the body as GLP-1 in the pancreas, which is often found in insufficient levels in type 2 diabetes patients. According to the ...